Serum levels of lymphokines and soluble cellular receptors in primary EpsteinBarr virus infection and in patients with chronic fatigue syndrome [PDF]
, 1992 The immunopathology in primary Epstein-Barr virus (EBV) infections and in chronic fatigue syndrome was studied by examining serum levelsof interleukins (IL) and of soluble T cell recep-tors in serum samples.
Hans Ahrne +12 more
core +1 more source
Epstein-Barr virus: Ubiquitous virus with multifarious implication in oral diseases [PDF]
Balkan Journal of Dental MedicineEpstein Barr virus (EBV) is the first virus identified to possess the capacity to induce various benign and malignant conditions. These conditions encompass asymptomatic persistent infection, self-limited disease in individuals with a competent immune ...
Koumpouli Alexandra +4 more
doaj +1 more source
microRNAs in the control of lymphocytes response [PDF]
, 2009 Recently, it has become evident the importance of miRNAs in regulating immune response, as well as immune cell development. During my phD fellow I focused my attention on the relationship B-lymphocytes-microRNA; in particular I examined two the different
Rossi, Annalisa
core
A structural investigation of the EpsteinBarr (EB) virus membrane antigen glycoprotein, gp340 [PDF]
, 1984 Epstein-Barr (EB) virus membrane antigen (MA) glycoprotein (gp340) purified by a molecular weight-based technique has been subjected to biochemical analysis.
A. J. Morgan +3 more
core
Precipitation of the EpsteinBarr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody [PDF]
, 1994 generated to the EBNA 3c nuclear protein from the B95.8 isolate of Epstein-Barr virus (EBV). Both antibodies efficiently precipitate EBNA 3c from B95.8-transformed lymphoblastoid cell lines, and E3cA10 also detects EBNA 3c on Western blots. Whereas E3cD8
Lisa Pettit +5 more
core
Progress toward an Epstein-Barr virus vaccine
Expert Review of VaccinesIntroduction Epstein-Barr virus (EBV), or Human gammaherpesvirus 4, infects over 90% of adults globally. While often asymptomatic in children, EBV causes infectious mononucleosis in adolescents and establishes lifelong latency in B lymphocytes.
Craig Laferriere +3 more
doaj +1 more source
Identification of minimal oriP of EpsteinBarr virus required for DNA replication [PDF]
, 1998 DNA replication from oriP of Epstein-Barr virus is mediated by the virus replication factor EBNA1 and cellular factors and occurs approximately once in each cell cycle.
Masaki Shirakata, Kanji Hirai
core
Multiple HLA-All-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the EpsteinBarr virus-encoded nuclear antigen 4 [PDF]
, 1993 Epstein-Barr virus (EBV), a ubiquitous herpesvirus, induces potent HLA class I-restricted cytotoxic T-lymphocyte (CTL) responses. Analyses of target antigen choice have shown that the very strong CTL responses which are often observed through the HLA All
Riccardo Gavioli +7 more
core
Control of the EBV growth transformation programme: the importance of the Bamhi W repeats [PDF]
, 2011 Epstein-Barr virus (EBV), a human gammaherpesvirus, possesses a unique set of latent genes whose constitutive expression in B cells leads to cell growth transformation.
Kao, Kuan-Yu
core
The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling [PDF]
, 2016 Approximately 20% of global cancer incidence is causally linked to an infectious agent. EpsteinBarr virus (EBV) accounts for around 1% of all virus-associated cancers and is associated with nasopharyngeal carcinoma (NPC). Latent membrane protein 1 (LMP1),
Christopher W. Dawson (7245977) +8 more
core